ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Sunovion Divests Asthma and Allergy Products to Covis
americanpharmaceuticalreview
July 18, 2017Sunovion?has entered into a definitive agreement to divest the U.S. market rights to Sunovion’s ciclesonide products ALVESCO Inhalation Aerosol, OMNARIS Nasal Spray, and ZETONNA Nasal Aerosol to Covis Pharma. Ciclesonides are included in the corticosteroi
Pharma Sources Insight January 2025
